Abstract
The role of radionuclide perfusion imaging during acute coronary syndromes are discussed. The development of Tc-99m sestamibi has provided for significant advances in this field. This radionuclide enables a measurement of myocardium at risk and final infarct size and, consequently, myocardial salvage during reperfusion therapy. Analysis of acute images during infarction also allows for a measure of collateral flow to the infarct zone. This agent also can be used to triage patients with spontaneous chest pain suggestive of unstable angina.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
